# Lumana Invest

> Lumana Invest is a VC fund in Heiloo backing Medical Device and Health Care. See 12 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Heiloo, The Netherlands
- Total investments: 12
- Last investment: Jun 2023
- Lead investor: 25%
- Last updated: Aug 2026
- Website: https://lumanainvest.nl/

Lumana Invest is a VC fund in Heiloo focused on Medical Device and Health Care. Lumana Invest stands for committed share ownership that supports management in strategic issues. Lumana prefers to invest in start-ups in new markets and new techniques. Explore boundaries with management and if possible push them back. Forward-looking and with the ambition to permanently change the future.

## Contacts

5 contacts available for Lumana Invest. Shizune tracks 1 team members at Lumana Invest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lumana-invest?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 5 | 42% |
| Health Care | 4 | 33% |
| Manufacturing | 4 | 33% |
| Nanotechnology | 4 | 33% |
| Medical | 3 | 25% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 4 | 33% |
| Funding Round | 3 | 25% |
| Seed | 2 | 17% |
| Series A | 2 | 17% |
| Series B | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Wim Smith | Founder & Managing Partner | 2 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vivolta | Vivolta engages in contract development and manufacturing of electrospun medical products. It provides nanofiber-based solutions that guide the human body to heal itself. | $7.6M | Series A | Jun 13, 2023 |  |
| ScoutinScience | ScoutinScience creates the SiS-AI platform technology, which searches all scientific (pre-)publications for hidden gems with high business potential. It assists TTOs and R&D departments in optimizing the impact of research, discovering new technologies, and gaining a competitive advantage.ScoutinScience strives to use artificial intelligence touncover untapped research and business opportunities. |  | Seed | Mar 30, 2023 |  |
| ATRO Medical | ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype. | $2.1M | Venture - Series Unknown | Dec 14, 2021 |  |
| Neuroplast | Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations. | $11.3M | Series B | Nov 17, 2021 |  |
| Sencure | Sencure develops chips that helps measure electrophysiological parameters on the human body in innovative ways. | $1.8M | Seed | Apr 28, 2021 |  |
| Eurekite | Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. | $2.2M |  | Feb 01, 2021 |  |
| Flexiramics | Flexiramics combines ceramic properties such as heat resistance and chemical stability with the flexibility and lightweight characteristics typically associated with polymers. The company supports use cases including high-frequency electronics, thermal management, battery components, and advanced filtration media. It collaborates with partners toco-develop materials tailored to specific performance and manufacturing requirements. Its offerings also extend to advisory and technical support for integrating these materials into commercial products. | $2.4M | Venture - Series Unknown | Feb 01, 2021 |  |
| IME Medical Electrospinning | IME Medical Electrospinning is a global leader in electrospun medical devices and regenerative medicine. Applying specific polymers, IME's advanced equipment creates fiber-based medical device solutions that mimic the natural human extracellular matrix in nanometer and micrometer format for implants and membranes in the human body. Human cellsrecognize this artificial matrix (scaffold) as the body's own facilitating the repair of the damaged tissue for heart valves, blood vessels, nerves, tendons, skin, and bone, etc. This is in contrast to implants and membranes of traditional structures, which are seen as foreign and therefore can lead to scar tissue or rejection phenomena. The MediSpin XL platform has been developed specifically for MedTech industrial manufacturing of medical devices and is now also suitable for pharmaceutical drug delivery applications and ensures the firm control of the crucial parameters of the electrospinning process, leading to identical and consistent end-products. | $3.3M |  | Sep 03, 2020 |  |
| Vivolta | Vivolta engages in contract development and manufacturing of electrospun medical products. It provides nanofiber-based solutions that guide the human body to heal itself. | $3.6M | Venture - Series Unknown | Sep 03, 2020 |  |
| LipoCoat | LipoCoat is a biotech spin-off from the University of Twente. The company has developed a coating technology which improves the safety and comfort of medical devices without using antibiotics or toxic substances. The LipoCoat® coatings are developed for medical devices, such as contact lenses, catheters and implants. The coating is bio-inspired,hydrophilic, anti-fouling, multi-purpose and sustainable. In the past 3 years, LipoCoat has won 15 awards, competitions and grants. | $1.6M | Series A | Apr 16, 2020 |  |

10 of 12 investments shown.

## Co-investors
- [Borski Fund](https://shizune.co/investors/profile/borski-fund) — VC Fund, 3 deals together
- [Brightlands Venture Partners](https://shizune.co/investors/profile/brightlands-venture-partners) — VC Fund, 3 deals together
- [NV Industriebank LIOF](https://shizune.co/investors/profile/nv-industriebank-liof) — VC Fund, 3 deals together
- [OostNL](https://shizune.co/investors/profile/oostnl) — VC Fund, 3 deals together
- [TIIN Capital](https://shizune.co/investors/profile/tiin-capital) — VC Fund, 3 deals together
- Demcon — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Lumana Invest invest in?

Lumana Invest invests primarily in Medical Device, Health Care and Manufacturing startups, most often at Venture - Series Unknown and Funding Round stage. Most of the 12 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Lumana Invest?

Public channels for Lumana Invest include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Lumana Invest?

The team at Lumana Invest includes Wim Smith (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co